QQQ   427.17 (+0.31%)
AAPL   167.86 (-0.08%)
MSFT   411.11 (-0.18%)
META   508.80 (+2.96%)
GOOGL   156.22 (+0.48%)
AMZN   182.13 (+0.47%)
TSLA   150.47 (-3.20%)
NVDA   856.55 (+1.93%)
AMD   156.25 (+1.45%)
NIO   4.04 (+3.32%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   114.41 (-1.65%)
GE   156.70 (+0.66%)
CGC   7.68 (+18.34%)
DIS   113.75 (+0.72%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.67 (-0.93%)
XOM   118.96 (+0.28%)
QQQ   427.17 (+0.31%)
AAPL   167.86 (-0.08%)
MSFT   411.11 (-0.18%)
META   508.80 (+2.96%)
GOOGL   156.22 (+0.48%)
AMZN   182.13 (+0.47%)
TSLA   150.47 (-3.20%)
NVDA   856.55 (+1.93%)
AMD   156.25 (+1.45%)
NIO   4.04 (+3.32%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   114.41 (-1.65%)
GE   156.70 (+0.66%)
CGC   7.68 (+18.34%)
DIS   113.75 (+0.72%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.67 (-0.93%)
XOM   118.96 (+0.28%)
QQQ   427.17 (+0.31%)
AAPL   167.86 (-0.08%)
MSFT   411.11 (-0.18%)
META   508.80 (+2.96%)
GOOGL   156.22 (+0.48%)
AMZN   182.13 (+0.47%)
TSLA   150.47 (-3.20%)
NVDA   856.55 (+1.93%)
AMD   156.25 (+1.45%)
NIO   4.04 (+3.32%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   114.41 (-1.65%)
GE   156.70 (+0.66%)
CGC   7.68 (+18.34%)
DIS   113.75 (+0.72%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.67 (-0.93%)
XOM   118.96 (+0.28%)
QQQ   427.17 (+0.31%)
AAPL   167.86 (-0.08%)
MSFT   411.11 (-0.18%)
META   508.80 (+2.96%)
GOOGL   156.22 (+0.48%)
AMZN   182.13 (+0.47%)
TSLA   150.47 (-3.20%)
NVDA   856.55 (+1.93%)
AMD   156.25 (+1.45%)
NIO   4.04 (+3.32%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   114.41 (-1.65%)
GE   156.70 (+0.66%)
CGC   7.68 (+18.34%)
DIS   113.75 (+0.72%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.67 (-0.93%)
XOM   118.96 (+0.28%)
NASDAQ:SURG

SurgePays (SURG) Stock Price, News & Analysis

$3.78
+0.02 (+0.53%)
(As of 11:45 AM ET)
Today's Range
$3.69
$3.85
50-Day Range
$3.66
$8.97
52-Week Range
$3.64
$9.23
Volume
65,095 shs
Average Volume
778,763 shs
Market Capitalization
$72.92 million
P/E Ratio
2.72
Dividend Yield
N/A
Price Target
$10.00

SurgePays MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
166.0% Upside
$10.00 Price Target
Short Interest
Healthy
8.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.82mentions of SurgePays in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.83 out of 5 stars

Computer And Technology Sector

315th out of 582 stocks

Telephone Communication, Except Radio Industry

9th out of 20 stocks

SURG stock logo

About SurgePays Stock (NASDAQ:SURG)

Surgepays Inc is a technology and financial services company specializing in providing distribution, logistics, and digital marketing services to convenience stores, bodegas, and other small retailers. The company was founded in 2016 and is headquartered in Bartlett, Tennessee. Surgepays is focused on helping small businesses compete against larger retailers by assisting them to provide telecommunications and fintech products and services. The company operates in a highly competitive industry and has been able to differentiate itself by leveraging its technology and logistics expertise.

The leadership team at Surgepays Inc comprises experienced professionals with backgrounds in technology, finance, and logistics. The company's CEO is Brian Cox, who has over 15 years of experience in the technology industry, including serving as the CTO of a publicly-traded company. The CFO is Anthony Evers, who has over 15 years of experience in finance and accounting, including working for a Big Four accounting firm. The President of Surgepays Fintech, Jeremy Gies, previously worked as their Senior Channel Business Manager at Honeywell Voice Solutions. Jeremy Gies has a long history of working in telecom sales and development. 

Surgepays Inc has experienced consistent revenue growth over the past few years but has also missed the mark on expected earnings per share (EPS) nearly every quarter for the past few years. The company has been working on increasing its gross profit margin and has made some upward movement regarding that. Surgepays has achieved this growth through a combination of organic growth and strategic acquisitions. The company recently reached a subscriber goal by passing over 200,000 subscribers in Q4 of 2022. However, the company is in debt, with a debt-to-equity ratio significantly higher than industry averages. The company has also recently completed a 1 for 50 reverse stock split, which has helped to reduce its outstanding shares and improve its financial position. Surgepays Inc's price-to-earnings ratio is significantly lower than the industry average, and the company's price-to-book ratio is also relatively low. These valuation metrics suggest that Surgepays may be undervalued relative to its peers. Surgepays Inc has had a volatile stock performance over the past year. The company has also experienced an increase in trading volume over the past year, with an average daily trading volume of around 100,000 shares daily.

Surgepays Inc operates in the highly competitive convenience store and bodega distribution industry, dominated by large retailers such as Walmart and Amazon. However, the company has been able to differentiate itself by focusing on small retailers and underserved customers in the fintech space. The industry also faces increasing regulatory and political pressures, primarily in online fraud through gift cards and "burner phones," often used for illegal purposes. 

Surgepays Inc has several potential growth opportunities, including expanding its product and service offerings, acquiring smaller competitors, and expanding into new markets. The company has recently launched a new ISO program, which has the potential to generate significant revenue growth. The company has also been actively seeking strategic acquisitions, focusing on companies that can help expand its geographic reach and product offerings.

Surgepays Inc faces several potential risks and challenges, including increasing competition from larger retailers, regulatory and political pressures, and the potential for economic downturns. The company's focus on small retailers is also a potential weakness, as these retailers are more susceptible to economic downturns and other market pressures. Surgepays must continue to innovate and differentiate itself to maintain its competitive position.

SURG Stock Price History

SURG Stock News Headlines

A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
3 Explosive Stocks to Turn $10K into $1M by 2030
A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”
Q4 2023 Surgepays Inc Earnings Call
Recap: Surgepays Q4 Earnings
Here's what Wall Street expects from SurgePays's earnings
Preview: Surgepays's Earnings
SurgePays: Flies Under The Radar
SURG Aug 2024 17.500 call
SURG Apr 2024 12.500 put
3 Small-Cap Stocks That Can Turn Your $100 Into $100,000
SURG Oct 2024 15.000 put
See More Headlines
Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
4/18/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Telephone communication, except radio
Sub-Industry
N/A
Current Symbol
NASDAQ:SURG
Fax
N/A
Employees
22
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.00
High Stock Price Target
$10.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+166.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$20.62 million
Pretax Margin
13.40%

Debt

Sales & Book Value

Annual Sales
$137.14 million
Cash Flow
$1.32 per share
Book Value
$1.68 per share

Miscellaneous

Free Float
13,619,000
Market Cap
$72.53 million
Optionable
Optionable
Beta
1.08
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Kevin Brian Cox (Age 49)
    Chairman & CEO
    Comp: $1.65M
  • Mr. Anthony George Evers CPA (Age 60)
    CIA, CPA, CFO & Acting COO
    Comp: $1.03M
  • Mr. David C. Ansani J.D. (Age 59)
    M.B.A., Director of Legal/Human Resources Services, Secretary & Chief Administrative Officer
    Comp: $423.83k
  • Mr. Jeremy Gies (Age 49)
    President
  • Mr. John MottMr. John Mott
    Chief Technology Officer
  • Mr. Carter M. Matzinger (Age 49)
    Chief Strategic Officer of LogicsIQ
    Comp: $187.21k
  • Mr. Brian M. Prenoveau C.F.A.
    Managing Director of MZ

SURG Stock Analysis - Frequently Asked Questions

Should I buy or sell SurgePays stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SurgePays in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SURG shares.
View SURG analyst ratings
or view top-rated stocks.

What is SurgePays' stock price target for 2024?

2 equities research analysts have issued 1 year price targets for SurgePays' shares. Their SURG share price targets range from $10.00 to $10.00. On average, they predict the company's share price to reach $10.00 in the next year. This suggests a possible upside of 166.0% from the stock's current price.
View analysts price targets for SURG
or view top-rated stocks among Wall Street analysts.

How have SURG shares performed in 2024?

SurgePays' stock was trading at $6.45 on January 1st, 2024. Since then, SURG stock has decreased by 41.7% and is now trading at $3.76.
View the best growth stocks for 2024 here
.

Are investors shorting SurgePays?

SurgePays saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,040,000 shares, a drop of 37.7% from the March 15th total of 1,670,000 shares. Based on an average daily volume of 855,400 shares, the short-interest ratio is presently 1.2 days. Currently, 8.0% of the company's stock are sold short.
View SurgePays' Short Interest
.

When is SurgePays' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our SURG earnings forecast
.

How were SurgePays' earnings last quarter?

SurgePays, Inc. (NASDAQ:SURG) issued its earnings results on Tuesday, March, 12th. The medical equipment provider reported $0.19 earnings per share (EPS) for the quarter. The medical equipment provider earned $32.32 million during the quarter. SurgePays had a net margin of 15.03% and a trailing twelve-month return on equity of 104.66%.

What other stocks do shareholders of SurgePays own?
Who are SurgePays' major shareholders?

SurgePays' stock is owned by a variety of institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%). Insiders that own company stock include David Allen May, John Mott and Kevin Brian Cox.
View institutional ownership trends
.

How do I buy shares of SurgePays?

Shares of SURG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SURG) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners